Evidence map›Paper›PMID 34939038›Full record

ArticleNature cancer2021

Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatment.

Catherine Gutierrez, Aziz M Al'Khafaji, Eric Brenner, Kaitlyn E Johnson, Satyen H Gohil, Ziao Lin, Binyamin A Knisbacher, Russell E Durrett, Shuqiang Li, Salma Parvin and 10 more

Open access · greenAbstract read
In one paragraph

Article in Nature cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Multiplexed enrichment and tracking of lineages with CloneSweeper.bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Deciphering precursor cell dynamics in esophageal preneoplasia via genetic barcoding and single-cell transcriptomics.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Cell lineage tracing: Methods, applications, and challenges.Quantitative biology (Beijing, China) · 2025
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 2 countries.

Catherine GutierrezHarvard Medical School, Boston, MA, USA.ORCID 0000-0001-7453-2577
Aziz M Al'KhafajiInstitute of Cellular and Molecular Biology, University of Texas at Austin, Austin, TX, USA.
Eric BrennerInstitute of Cellular and Molecular Biology, University of Texas at Austin, Austin, TX, USA.ORCID 0000-0001-6755-0910
Kaitlyn E JohnsonDepartment of Biomedical Engineering, University of Texas at Austin, Austin, TX, USA.
Satyen H GohilHarvard Medical School, Boston, MA, USA.
Ziao LinHarvard Medical School, Boston, MA, USA.ORCID 0000-0002-8495-6995
Binyamin A KnisbacherBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0002-4962-9956
Russell E DurrettInstitute of Cellular and Molecular Biology, University of Texas at Austin, Austin, TX, USA.
Shuqiang LiDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Salma ParvinDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0001-6111-1212
Anat BiranDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Wandi ZhangDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Laura RassentiDepartment of Medicine, University of California at San Diego Moores Cancer Center, La Jolla, CA, USA.
Thomas J KippsDepartment of Medicine, University of California at San Diego Moores Cancer Center, La Jolla, CA, USA.
Kenneth J LivakDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0001-9105-5856
Donna NeubergDepartment of Data Sciences, Dana Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0003-2566-3145
Anthony LetaiHarvard Medical School, Boston, MA, USA.ORCID 0000-0002-1993-9013
Gad GetzHarvard Medical School, Boston, MA, USA.ORCID 0000-0002-0936-0753
Catherine J WuHarvard Medical School, Boston, MA, USA.ORCID 0000-0002-3348-5054
Amy BrockInstitute of Cellular and Molecular Biology, University of Texas at Austin, Austin, TX, USA.ORCID 0000-0001-8255-9024
Broad Institute · USDana-Farber Cancer Institute · USThe University of Texas at Austin · USHarvard University · USUniversity of California San Diego · USSt. Catherine University · US

Funding

ProteomicsP01CA206978 · NCI · DANA-FARBER CANCER INST · PI WU, CATHERINE JU-YING · 2016 to 2025
$17.0M
ITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" TherapieU10CA180861 · NCI · OHIO STATE UNIVERSITY · PI BLOOMFIELD, CLARA D, MARCUCCI, GUIDO · 2014 to 2018
$3.4M
The Allee Effect in Tumor InitiationR01CA226258 · NCI · UNIVERSITY OF TEXAS AT AUSTIN · PI BROCK, AMY, HUANG, SUI · 2018 to 2022
$2.3M
Single cell investigation of co-evolution in cancer cells and host cell immune microenvironmentR50CA251956 · NCI · DANA-FARBER CANCER INST · PI Shuqiang Li · 2020 to 2026
$1.4M
High resolution cell lineage tracking and isolationR21CA212928 · NCI · UNIVERSITY OF TEXAS AT AUSTIN · PI BROCK, AMY · 2017 to 2019
$559k
NCI NIH HHS P01 CA206978NCI NIH HHS R01 CA226258NCI NIH HHS R21 CA212928NCI NIH HHS R50 CA251956NCI NIH HHS U10 CA180861
6 · The paper itself

Abstract

Lineage-tracing methods have enabled characterization of clonal dynamics in complex populations, but generally lack the ability to integrate genomic, epigenomic and transcriptomic measurements with live-cell manipulation of specific clones of interest. We developed a functionalized lineage-tracing system, ClonMapper, which integrates DNA barcoding with single-cell RNA sequencing and clonal isolation to comprehensively characterize thousands of clones within heterogeneous populations. Using ClonMapper, we identified subpopulations of a chronic lymphocytic leukemia cell line with distinct clonal compositions, transcriptional signatures and chemotherapy survivorship trajectories; patterns that were also observed in primary human chronic lymphocytic leukemia. The ability to retrieve specific clones before, during and after treatment enabled direct measurements of clonal diversification and durable subpopulation transcriptional signatures. ClonMapper is a powerful multifunctional approach to dissect the complex clonal dynamics of tumor progression and therapeutic response.

Indexed as

Leukemia, Lymphocytic, Chronic, B-CellCell LineClone CellsGenomicsHumansTranscriptome

Identifiers

PMID34939038
PMCPMC8691751
OpenAlexW3179869469

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.